Search Results 411-420 of 17889 for testosterone

  1. Prostate cancer - Doctors and departments - Mayo Clinic

    Testosterone and prostate cancer: What's the connection? Transrectal biopsy of the prostate · Types of prostate cancer: Common and rare forms · What is prostate ...

  2. Treating advanced prostate cancer - Mayo Clinic News Network

    Radiopharmaceuticals offer new hope. Prostate cancer cells rely on testosterone to help them grow. Hormone therapy, a treatment to stop your body from producing ...

  3. A Study of Treatment with Docetaxel and Prednisone, with or without Vaccine Therapy, for Patients who have Metastatic Hormone-Resistant Prostate Cancer - Mayo Clinic

    Must have castration levels of testosterone (< 50 ng/dL) within 4 weeks prior to randomization. Must have progressive disease while receiving ADT as defined ...

  4. A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer - Mayo Clinic

    Histologically or cytologically confirmed adenocarcinoma of the prostate · Ongoing androgen blockade demonstrated by serum testosterone concentration of less ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  6. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    A Mayo Clinic study finds postmenopausal women using hormone therapy lost 35% more weight with tirzepatide, suggesting new obesity treatment strategies.

  7. Blood in semen - Mayo Clinic

    Prostate cancer: Does PSA level affect prognosis? SBRT for prostate cancer: How it compares to other treatments · Testosterone and prostate cancer: What's the ...

  8. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    The purpose of this study is to retrospectively and prospectively compare maternal and fetal/newborn clinical outcomes in age-matched pregnant patients with ...

  9. Androgen Deprivation To Enrich PSMA Expression And Improve Sensitivity Of Staging PSMA PET/C - Mayo Clinic

    Testosterone greater than or equal to 300 ECOG Performance Status (PS) 0, 1 or 2 (Appendix I). The following laboratory values obtained ≤ 60 days prior to ...

  10. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    Patients must have castrate levels of testosterone (<50 ng/dl [1.74 nmol/l]). Patients must have undergone orchiectomy, or have been on LHRH agonists or ...